KC

Kristof Chwalisz

SC Schering: 14 patents #195 of 2,442Top 8%
AV Abb Vie: 4 patents #384 of 1,257Top 35%
US University Of Texas System: 2 patents #22 of 217Top 15%
University Of Texas System: 2 patents #1,567 of 6,559Top 25%
MC Medical Research Council: 1 patents #161 of 405Top 40%
BA Bayer Schering Pharma Ag: 1 patents #205 of 464Top 45%
BP Bayer Pharma: 1 patents #440 of 819Top 55%
ES Eastern Virginia Medical School: 1 patents #34 of 79Top 45%
📍 Berlin, IL: #1 of 14 inventorsTop 8%
Overall (All Time): #171,470 of 4,157,543Top 5%
24
Patents All Time

Issued Patents All Time

Showing 1–24 of 24 patents

Patent #TitleCo-InventorsDate
11707464 Methods of treating heavy menstrual bleeding Laura A. Williams, Rita I. Jain, Janine D. North, Juki Wing-Keung Ng 2023-07-25
11344551 Methods of treating heavy menstrual bleeding Laura A. Williams, Rita I. Jain, Janine D. North, Juki Wing-Keung Ng 2022-05-31
11045470 Methods of treating heavy menstrual bleeding Laura A. Williams, Rita I. Jain, Janine D. North, Juki Wing-Keung Ng 2021-06-29
10881659 Methods of treating heavy menstrual bleeding Laura A. Williams, Rita I. Jain, Janine D. North, Juki Wing-Keung Ng 2021-01-05
8193252 Mesoprogestins (progesterone receptor modulators) for the treatment and prevention of benign hormone dependent gynecological disorders Walter Elger, Gerd Shubert 2012-06-05
7629334 Mesoprogrestins (progesterone receptor modulations) as a component of compositions for hormone replacement therapy (HRT) Walter Elger, Gerd Schubert 2009-12-08
7538099 Antiprogestin method and kit for reducing side effects associated with low dosage HRT, oral contraception and regulating menses Gary D. Hodgen 2009-05-26
7148213 Antigestagenically active steroids with a fluorinated 17α-alkyl chain Wolfgang Schwede, Arwed Cleve, Ulrich Klar, Gunter Neef, Martin Schneider +2 more 2006-12-12
6806263 Antigestagenically active steroids with a fluorinated 17-alpha-alkyl chain Wolfgang Schwede, Arwed Cleve, Ulrich Klar, Gunter Neef, Martin Schneider +2 more 2004-10-19
6613757 COMBINATION OF PROSTACYCLIN WITH AN ESTROGEN OR PROGESTIN FOR THE PREVENTION AND TREATMENT OF ATHEROSCLEROTIC VASCULAR DISEASE INCLUDING PREECLAMPSIA AND FOR THE TREATMENT OF HYPERTENSION, AND FOR HORMONE REPLACEMENT THERAPY Robert E. Garfield 2003-09-02
6503895 Antigestagenically active steroids with a fluorinated 17&agr;-alkyl chain Wolfgang Schwede, Arwed Cleve, Ulrich Klar, Gunter Neef, Martin Schneider +2 more 2003-01-07
6362237 Compounds with progesterone-antagonistic and antiestrogenic action to be used together for female contraception Klaus Stockemann 2002-03-26
6333350 Use of nitric oxide donors and/or substrates or nitric oxide inhibitors for regulating cervical dilatation and extensibility Robert E. Garfield 2001-12-25
6316432 Antigestagenically active steroids with a flourinated 17 .alpha.-alkyl chain Wolfgang Schwede, Arwed Cleve, Ulrich Klar, Gunter Neef, Martin Schneider +2 more 2001-11-13
6225297 Combination contraceptive Klaus Stockemann 2001-05-01
6143754 Competitive progesterone antagonist for demand-oriented female birth control Klaus Stockemann, Karin Schmidt-Gollwitzer, Walter Klemann 2000-11-07
6096732 Steroid esters, process for their production and their pharmaceutical use Ulrich Klar, Arwed Cleve, Wolfgang Schwede, Gunter Neef, Eckhard Ottow +1 more 2000-08-01
6043234 Method for treating endometriosis or leiomyomata uteri with a competitive progesterone antagonist and a gestagen Klaus Stockemann 2000-03-28
6028106 Treatment of urinary incontinence with nitric oxide synthase substrates and/or nitric oxide donors alone or in combination with estrogen or progesterone and/or other agents Robert E. Garfield 2000-02-22
5906987 Treatment of male climacteric disorders with nitric oxide synthase substrates and/or donors, in combination with androgens and/or aromatase inhibitors Robert E. Garfield 1999-05-25
5811416 Endothelin antagonist and/or endothelin synthase inhibitor in combination with a progestin, an estrogen, a cyclooxygenase inhibitor, or a nitric acid donor or substrate Robert E. Garfield 1998-09-22
5789442 Treatment of urinary incontinence with nitric oxide synthase substrates and/or nitric oxide donors alone or in combination with estrogen or progesterone and/or other agents Robert E. Garfield 1998-08-04
5719136 Combination of progesterone antagonists and antiestrogens with partial agonistic action for hormone substitution therapy for perimenopausal and postmenopausal women Klaus Stockemann 1998-02-17
5624670 Use of interleukin-8 for inducing cervical ripening Rodney Kelly, Radostaw Bukowski, Peter Scholz 1997-04-29